key: cord-0797991-bl1bkuha authors: Cervantes‐Silva, Mariana P; Cox, Shannon L; Curtis, Annie M title: Alterations in mitochondrial morphology as a key driver of immunity and host defence date: 2021-08-02 journal: EMBO Rep DOI: 10.15252/embr.202153086 sha: 1a071d28b204eb51cadaad2553203eac63b766af doc_id: 797991 cord_uid: bl1bkuha Mitochondria are dynamic organelles whose architecture changes depending on the cell’s energy requirements and other signalling events. These structural changes are collectively known as mitochondrial dynamics. Mitochondrial dynamics are crucial for cellular functions such as differentiation, energy production and cell death. Importantly, it has become clear in recent years that mitochondrial dynamics are a critical control point for immune cell function. Mitochondrial remodelling allows quiescent immune cells to rapidly change their metabolism and become activated, producing mediators, such as cytokines, chemokines and even metabolites to execute an effective immune response. The importance of mitochondrial dynamics in immunity is evident, as numerous pathogens have evolved mechanisms to manipulate host cell mitochondrial remodelling in order to promote their own survival. In this review, we comprehensively address the roles of mitochondrial dynamics in immune cell function, along with modulation of host cell mitochondrial morphology during viral and bacterial infections to facilitate either pathogen survival or host immunity. We also speculate on what the future may hold in terms of therapies targeting mitochondrial morphology for bacterial and viral control. The immune system is crucial for host survival and defence against foreign invaders such as bacteria, viruses and parasites. This system is an ensemble of specialised organs, cells and molecules, which sense and protect the host from pathogen infection (Delves & Roitt, 2000) . The innate immune response is the non-specific, rapid first line of defence against infection and involves the recruitment and activation of granulocytes, monocytes, macrophages, dendritic cells and natural killer cells. The adaptive immune response is the highly specific second line of defence, and a slower and long-lasting response consisting of T and B cells (Parkin & Cohen, 2001) . Together these cells recognise the foreign agent and mount an inflammatory response, which, if successful, results in elimination of the pathogen, resolution of inflammation, return to tissue homeostasis and a memory of the pathogen should reinfection occur (Ayala et al, 2008) . What has become apparent over the last decade is that each immune cell has different metabolic requirements directing their effector function during discrete stages of the immune response against pathogens (O'Neill et al, 2016) . This has given rise to a new field called immunometabolism. Due to this emerging field, we now appreciate the critical role which mitochondria play in modulating the immune response and this is the major topic of this review. Ask any undergraduate student what mitochondria do, and you will get the same response delivered with gusto "mitochondria are the powerhouse of the cell". Certainly, mitochondria through the electron transport chain (ETC) are uniquely specialised to meet the cell's energy requirement by producing adenosine triphosphate (ATP) via oxidative phosphorylation (OxPhos). Nonetheless, it is now unequivocally clear that mitochondria play a multitude of cellular functions beyond energy production (McBride et al, 2006) . We now appreciate that mitochondria are essential organelles directing the fate and function of innate and adaptive immune cells (Angajala et al, 2018) . Mitochondria are vital for modulating immune cell activation, differentiation, metabolism, effector functions and immune survival (Rambold & Pearce, 2018) . Therefore, it makes sense that, upon invasion, numerous pathogens would target mitochondria in an attempt by the pathogen to manipulate this organelle for its own advantage. Mitochondria are double-membrane bound organelles consisting of an outer membrane (OMM) and an inner membrane (IMM), with an intermembrane space (IMS) in between. Multiple proteins reside in the OMM including mitochondrial anti-viral signalling protein (MAVS) (Horner et al, 2011) , mitochondrial fusion proteins MFN1 and MFN2 (Chen et al, 2003) , anti-apoptotic proteins and mitochondrial voltage-dependent anion channel (VDAC) . Changes in OMM permeability allows the OMM to act as a signalling platform between the cytosol and mitochondria, with VDAC facilitating the transport of ions and small molecules . The IMM contains the fusion protein OPA1, as well as the electron transport chain (ETC), which facilitates the generation of ATP via OxPhos (Rambold & Pearce, 2018) . The ETC is also the main producer of reactive oxygen species (mtROS), which is crucial for anti-pathogenic responses by directly killing the pathogen, or mtROS can activate other pathways such as pathogen recognition receptor (PRR) activation and neutrophil extracellular trap (NET) formation (Pinegin et al, 2018) . Mitochondria are also intrinsically involved in cell death processes such as necroptosis, apoptosis and pyroptosis. Pyroptosis relies on the activation of inflammasomes via mtROS release into the cytosol, a mechanism necessary for the production of proinflammatory mediators (Wang et al, 2019) . Mitochondrial dynamics as we will describe below in more detail plays a crucial role in mitochondrial function. Pathogens have evolved mechanisms to manipulate mitochondrial dynamics, leading to mitochondrial dysfunction and persistent infection. In this review, we will first discuss the mechanisms driving mitochondrial remodelling. Next, we discuss how mitochondrial dynamics directs immune cell function through the process of inflammation. Then, we review how pathogens or the host alters the mitochondrial architecture in infected cells in the battle between pathogen and host. We discuss what therapeutic opportunities may exist in exploiting mitochondrial dynamics for antimicrobial and anti-viral control. Finally, we conclude on many of the outstanding questions which exist in this field and what the future might hold for mitochondrial dynamics in immunity. Mitochondrial dynamics refers to the dynamic remodelling of the mitochondrial network with regard to size, shape, activity, trafficking and connectivity of this organelle. Mitochondrial dynamics is determined by the equilibrium of fission versus fusion. Although arbitrary, fission is normally characterised by punctuated mitochondria (less than 1 µm in length), and fusion characterised by interlocking connected networks of mitochondria (greater than 3 µm in length) (Park et al, 2013; Collins et al, 2021; Dowling et al, 2021) . We will first address the constituents and molecular pathways which dictate the process of mitochondrial fusion and fission. Following Severe acute respiratory syndrome Spire1c Spire type actin nucleation factor 1 that we will then discuss the role of mitochondrial fusion and fission in immune cell metabolism and the response to infection. While mitochondrial dynamics was first observed over 100 years (Lewis & Lewis, 1914) , the proteins dictating mitochondrial morphology have been identified and extensively studied in the past 20+ years. Clearly, as the name suggests, mitochondrial dynamics is a highly dynamic process, with changes to mitochondrial morphology reflecting the cell's adaptation to its surrounding environment. Mitochondrial morphology is a spectrum, with fission and fusion occupying extremities of the morphological spectrum (Galloway et al, 2012) . Mitochondria are constantly changing their morphology depending on the cell's metabolic requirements. Mitochondrial fusion occurs in 2 stages: first, (1) fusion of the OMM occurs after the interaction of MFN1 and MFN2 which allows for increased surface area contact between the two mitochondria. (2) Fusion of the IMM occurs almost simultaneously and is mediated by the GTPase OPA1 that is anchored to the IMM. Mitochondrial fission involves the division of a single mitochondrion into two separate daughter mitochondria. Mitochondrial fission involves contact between the endoplasmic reticulum (ER) and the mitochondria mediated by actin cytoskeletal proteins which carry out constriction of the mitochondria. Once constriction occurs, DRP1 is recruited to fission sites at the mitochondria. DRP1 recruitment is regulated by FIS1, MFF, MiD51 and MiD49, which are adaptor proteins located on the OMM. Thus, depending on the extracellular conditions, cells will lean to either fusion or fission morphology (Zemirli et al, 2018) . In order to do so, cells employ an intricate network of proteins, which act to increase one morphological state while inhibiting the other. The process of mitochondrial fusion Fusion involves the fusion of the OMM and IMM resulting in the joining of two mitochondria into one. OMM fusion occurs first and is then swiftly followed by IMM fusion (Fig 1) . MFN1 and MFN2 mediate fusion of the OMM through homo-and heterotypic interactions powered by guanosine-5'-triphosphate (GTP) hydrolysis. Briefly, fusion of the OMM occurs in three steps: (1) OMM tethering between two mitochondria mediated by the MFNs, (2) interaction of MFN1 and MFN2 with their C-termini to allow for tethering of neighbouring mitochondria in trans leading to increased surface area contact between the two mitochondria (Brandt et al, 2016) and (3) GTP hydrolysis-mediated conformational changes leading to OMM fusion (Ishihara et al, 2004) . Fusion of the IMM occurs almost simultaneously with fusion of the OMM and is mediated by the GTPase OPA1 (Sesaki et al, 2003) . OPA1 is anchored to the IMM by its N-terminal, and upon fusion of the OMM, OPA1 is cleaved into two forms: a long (L) form and a short (S) form. This proteolytic cleavage is carried out by metalloproteases YME1L and OMA1 in the mitochondria intermembrane space (IMS) (Song et al, 2007; Ehses et al, 2009 ). Cleavage of OPA1 generates numerous protein isoforms consisting of higher molecular weight membrane-anchored L-forms (L-OPA1) and non-membraneanchored S-forms (S-OPA1) (Wang et al, 2021) . The individual roles of OPA1 isoforms are reviewed in detail elsewhere (Del Dotto et al, 2018) . Fusion of mitochondria in a cell is associated with increased OxPhos and ATP production and is characterised by elongated mitochondria (Mishra & Chan, 2016) . The process of mitochondrial fission Whereas fusion produces networks of interconnected mitochondria, the process of fission then breaks up that network into distinct fragments Mitochondrial fission involves the division of a single mitochondrion into two separate daughter mitochondria. Similar to fusion, fission occurs at both OMM and IMM, with OMM fission mediated by the cytosolic GTPase DRP1 (Fig 1) (Bleazard et al, 1999; Labrousse et al, 1999) . Initiation of mitochondrial fission involves contact between the endoplasmic reticulum (ER) and the mitochondria mediated by actin cytoskeletal proteins such as spiretype actin nucleation factor 1 (Spire1c) and inverted formin 2 (INF2) (Friedman et al, 2011; Korobova et al, 2013; Manor et al, 2015) . These proteins carry out constriction of the mitochondria. Once constriction occurs, dynamin-related protein 1 (DRP1) is recruited to fission sites at the mitochondria. DRP1 recruitment is regulated by fission protein 1 (FIS1), mitochondrial fission factor (MFF), MiD51 and MiD49 which are adaptor proteins located on the OMM (Osellame et al, 2016) . Moreover, DRP1 activity is also regulated by signalling events. For example, mitochondrial fission occurs when DRP1 is dephosphorylated by the phosphatase calcineurin at Ser637, a process which is regulated by calcium content and will be discussed later on (Cereghetti et al, 2008) . DRP1, upon recruitment, forms oligomeric rings, which promotes mitochondrial scission by GTPase hydrolysis-mediated conformational changes that constricts the rings (Mears et al, 2011) . Although mechanisms surrounding OMM fission are well documented, mechanisms driving IMM fission are less understood. The IMM protein mitochondrial fission process 1 (MTFP1) appears to mediate IMM fission. Overexpression of MTFP1 increases mitochondrial fission, while its loss leads to mitochondrial fusion (Tondera et al, 2005) . Moreover, Morita et al found that MTFP1 is a modulator of DRP1 phosphorylation, the significance of which is detailed below (Morita et al, 2017) . Other proposed mechanisms of IMM fission are reviewed in detail elsewhere (Tilokani et al, 2018) . Mitophagy, the process of mitochondrial clearance Mitochondrial autophagy, known as mitophagy, is necessary for the clearance of dysfunctional mitochondria and is regulated by fission and fusion. Clearance of damaged mitochondria is necessary for maintaining the quality of mitochondria and avoids cell apoptosis (Kubli & Gustafsson, 2012) . Ubiquitin-dependent mitophagy is controlled by the PINK1/parkin pathway. PINK1 which is a serine/ threonine protein kinase accumulates in the OMM resulting in parkin recruitment to the mitochondria (Lazarou et al, 2015) . This process is promoted by fission and inhibited by fusion (Twig et al, 2008) . Parkin recruitment initiates degradation of OMM proteins via ubiquitination, as parkin is a component of a multiprotein E3 ubiquitin ligase complex (Kane et al, 2014; Kazlauskaite et al, 2014; Koyano et al, 2014) . This triggers formation of autophagosomes to remove damaged mitochondria from the cell (Rodriguez-Enriquez et al, 2006) . Other mechanisms of mitophagy include receptormediated mitophagy. This involves the localisation of the mitophagy receptors BNIP3, NIX and FUNDC1 to the OMM where they interact with LC3 to mediate mitochondrial clearance. These mitophagy receptors ultimately promote fission and subsequent clearance of damaged mitochondria by releasing OPA1 and recruiting DRP1 to the mitochondrial surface (Palikaras et al, 2018) . As we will see later on, mitophagy is a crucial process for many immune cell functions and implicated in pathogen clearance. Mitochondrial fission and fusion are rapid processes dependent on the coordination of numerous proteins in response to various stimuli, such as nutrient availability including glucose levels. For example, in diabetes studies, sustained exposure of heart myoblast cells to high glucose conditions results in fragmented mitochondria (Yu et al, 2008) . Thus, transcriptional regulation of mitochondrial dynamic proteins is too slow. As such, most of the regulation of mitochondrial remodelling occurs through post-translational modifications (PTMs) (Tilokani et al, 2018) . PTMs are key regulators of mitochondrial proteins, which allow for swift and efficient switching to fission and fusion in response to physiological demands. PTMs such as phosphorylation, acetylation, SUMOylation, O-GlcNAcylation and ubiquitination differentially regulate mitochondrial proteins and the mitochondrial network to meet the cell's requirements. Reversible phosphorylation of mitochondrial proteins in particular is a well-documented regulatory mechanism of mitochondrial dynamics. The phosphorylation status of DRP1 on serine residues including serine 616 and serine 637 determines mitochondrial morphology (Archer, 2013) . Mitochondria control cellular localisation and levels of calcium. Many of the metabolic enzymes and proteins within the ETC and the tricarboxylic acid cycle (TCA) are calcium-dependent and are reviewed elsewhere . Mitochondria sense and take up calcium via the mitochondrial calcium uniporter and release calcium into the cytosol via efflux channels (Kirichok et al, 2004) . The changes in calcium levels and links to mitochondrial dynamics are complex. Increased cytosolic Ca 2+ activates the phosphatase calcineurin which dephosphorylates DRP1 at Ser637, leading to mitochondrial fission, promotion of mitophagy and sometimes apoptosis of the cell (Cereghetti et al, 2008) . On the other hand, Ca 2+ influx into mitochondria has also been associated with fission of the IMM via OPA1 processing to S-OPA1 (Cho et al, 2017) , and increased Ca 2+ influx is reported to inhibit fusion by inhibiting the oligomerisation of MFN1 (Ishihara et al, 2017) . Mitochondria can sense the second messenger cyclic adenosine monophosphate (cAMP) signalling at the OMM, and this is a major regulator of mitochondrial fission and fusion. cAMP activates protein kinase A (PKA), which phosphorylates DRP1 at Ser656, leaving DRP1 inactive in the cytosol and maintaining fusion (Cribbs & Strack, 2007) . Activation of PKA is also associated with increased OxPhos and cell survival (Ould Amer & Hebert-Chatelain, 2018) . There are many more regulatory mechanisms of fission and fusion, allowing mitochondria to function correctly and efficiently. This is especially important in immune cells, as mitochondrial dynamics affect numerous aspects of the immune response to infection. As we will see below, mitochondrial remodelling affects immune cell metabolism, activation, differentiation and cytokine production. The host immune response to infection is an orchestrated response mediated by the temporal coordination of specific immune cells. Starting with pathogen sensing, an inflammatory response is mediated by chemokine and cytokine production, along with increased immune cell recruitment, pathogen clearance and finally resolution. Immune cells have different metabolic requirements during each stage of the host immune response and mitochondria play a critical role in modulating the appropriate response. One of the first events in the immune response is the recruitment of neutrophils to the site of infection by chemo-attractants (Parkin & Cohen, 2001) . Upon reaching the site of infection, neutrophils employ various mechanisms in order to eliminate pathogens. These mechanisms include phagocytosis, production of mtROS, secretion of granules and the release of pro-inflammatory cytokines and NETS, all of which promotes pathogenic clearance (Mayadas et al, 2014) . Neutrophils remodel their mitochondria depending on their activation stage. Nascent neutrophils exhibit tubular mitochondria while non-surviving neutrophils exhibit an "aggregation" of mitochondria, which is presumed to drive apoptosis (Maianski et al, 2002) . The formation of NETs is dependent on mitochondrial fusion, as deletion of OPA in neutrophils, decreased ATP levels which is required for microtubule network assembly and NET formation (Fig 2) . OPA deletion in mice reduced anti-bacterial defence against Pseudomonas aeruginosa (Amini et al, 2018) . MFN2, through suppression of Rac activation, controls neutrophil adhesive migration, and MFN2 deletion results in a significant reduction of neutrophil infiltration to the inflamed peritoneal cavity in mice (Zhou et al, 2021) . Calcium levels are crucial for neutrophil polarisation and chemotaxis (Immler et al, 2018) . Neutrophil polarisation using N-formylmethionyl-leucyl-phenylalanine (fMLP), a prototypic neutrophil chemotactic factor, induced mitochondrial fission in neutrophils via increased phosphorylation of DRP1 (Ser616). Mitochondrial calcium uniporter (MCU) complex activity was shown to be necessary for this increased fission and DRP1 phosphorylation (Ser616), as inhibition of MCU downregulated DRP1 (Ser616) (Zheng et al, 2017) . Mast cells are tissue-resident immune cells which have high expression of IgE receptor (FceRI) and are involved in pathogenic clearance as well as allergic diseases. The presence of IgE and environmental triggers such as neuropeptides leads to degranulation and release of histamine and pro-inflammatory cytokines such as tumour necrosis factor (TNF) (Parkin & Cohen, 2001; Zhang et al, 2011) . Mast cell activation via FceRI leads to mitochondrial fission and translocation of mitochondria to secretory granule exocytosis sites. Inhibition of DRP1 activity by Mdivi-1 treatment decreased mitochondrial translocation and subsequent degranulation, indicating the importance of mitochondrial fission in the mast cell immune response (Fig 2) (Zhang et al, 2011) . Monocytes are phagocytes which participate in the innate immune response and have the potential to differentiate into macrophages and dendritic cells. The plasticity of monocytes allows for a tailored immune response depending on many factors such as Toll-like receptor (TLR) stimulation, and mitochondria are crucial for monocyte adaptation to environmental cues (Merah-Mourah et al, 2020). During TLR4 stimulation with lipopolysaccharide (LPS), CD14+ human monocytes become activated which involved reduced expression of MTFP1 and increased mitochondrial fusion. This was required for the metabolic adaptation of monocytes to LPS stimulation, necessary for pro-inflammatory cytokine and chemokine expression (Duroux-Richard et al, 2016) . Moreover, mitochondrial elongation is also observed during murine monocyte to macrophage differentiation . Monocytes are a heterogenous population of cells, further studies are needed to determine the exact role of mitochondrial dynamics in each of the different subsets. Macrophages are long-lived key innate immune cells and were first described by Metchnikoff well over 100 years ago (Metchnikoff, 1883). They are multifunctional phagocytes, which can detect, engulf and destroy pathogens and apoptotic cells. They are the main producers of cytokines and are involved in resolution of inflammation and tissue repair. Due to their range of functions throughout the inflammatory response to infection, it is unsurprising that their dysfunction contributes significantly to the pathogenesis of a range of inflammatory and degenerative diseases (Wynn et al, 2013) . Activated macrophages are traditionally divided into two categories, M1-like versus M2-like. M1 macrophages are mainly involved in pro-inflammatory responses and the spectrum of M2 macrophages are mainly involved in anti-inflammatory, pro-resolution responses, although these definitions are strongly oversimplified as macrophage phenotype is vastly more complex in vivo (Mosser & Edwards, 2008; Orecchioni et al, 2019) . Bone marrow-derived macrophages (BMDMs) are often stimulated with TLR4 ligand LPS as a model of M1 polarisation. In this scenario, time-lapse microscopy showed that mitochondria switched to a fragmented morphology within 2 hours of LPS stimulation, and expression of fusion mitochondrial proteins MFN1, MFN2 and phosphorylation of DRP1 (Ser637) was suppressed. This increase in fragmentation also correlated with an increase in mitochondrial mtROS production (Gao et al, 2017) . IL-4 stimulation of BMDMs is known to promote M2 polarisation and which causes macrophage mitochondria to form elongated tubules occupying more cytoplasmic area in the cell (Fig 2) (Gao et al, 2017) . Studies have shown that mitochondrial dynamics are also critical in macrophage function. For example, increased mitochondrial fusion and mitochondrial activity precedes increased macrophage phagocytic and bactericidal activity against Salmonella typhimurium infection (Fig 2) (Oliva-Ram ırez et al, 2014). Macrophages can prevent post-apoptotic necrosis and dampen inflammation through clearance of apoptotic cells by phagocytosis, a process known as efferocytosis. Macrophage uptake of multiple apoptotic cells requires DRP1-mediated mitochondrial fission, as silencing Drp1 led to impaired efferocytosis in these macrophages. Inhibition of mitochondrial fission led to a striking increase of necrotic core area and the accumulation of apoptotic cells in vitro and in thymus tissue in vivo. Therefore, changes in mitochondrial dynamics underpin macrophage efferocytosis, a process which is critical for normal tissue homeostasis . What has become increasing clear over the past decade is that macrophages are highly controlled by our molecular clock. This molecular clock imparts 24 rhythms, or circadian rhythms in biological function so as to align with the daily changes in our environment. The breadth of circadian control over both monocyte and macrophage function has been reviewed in detail here (Timmons et al, 2020) . Circadian rhythms provide a selective advantage by anticipating organismal nutrient needs and guaranteeing optimal metabolic capacity and performance during active versus rest phases. We now observe that the macrophage immune response to both bacterial and viral infection is conditioned by time of day of exposure (Bellet et al, 2013; Sengupta et al, 2019) . Remarkably, mouse macrophages alter their mitochondrial morphology over the course of the day, such that mitochondria are more fused during the rest phase and more fragmented during the active phase. This change in morphology also maps to circadian changes in metabolism such as ATP production and function such as phagocytosis (Collins et al, 2021) . Further research is needed to fully understand the exact impact of these daily rhythms in macrophage mitochondria morphology and how this may impact the macrophage response to infection at discrete times of day. Further work is also required to understand the impact of circadian disruption, which is evident in shift workers, on this rhythmic cycling of mitochondrial dynamics in macrophages and also what additional immune cells also possess this intriguing feature. The inflammasome is a multiprotein intracellular complex and is one of the most important mechanisms for innate immune defence against microbial infection. The inflammasome detects pathogenic microorganisms and damage-associated molecular patterns (DAMPs) such as mtROS, which activates the highly pro-inflammatory cytokines interleukin-1b (IL-1b) and IL-18. The role of mitochondria in regulating the activation of the NLR family pyrin domain-containing 3 (NLRP3) inflammasome has garnered much interest in recent years and have been extensively reviewed (Liu et al, 2018) . In macrophages, knockdown of Drp1 led to aberrant mitochondrial elongation and increased NLRP3-dependent caspase-1 activation and IL-1b secretion. NLRP3 inflammasome assembly is determined by NLRP3-ASC interaction and apoptosis-associated speck-like (ASC) oligomerisation, both of which were much stronger in Drp1-knockdown BMDMs. Treatment with the mitochondrial ETC uncoupler carbonyl cyanide m-chlorophenylhydrazone (CCCP) is known to induce mitochondrial fission in cells. Interestingly, treatment of BMDMs with CCCP led to mitochondrial fission, but also attenuated assembly and activation of the NLRP3 inflammasome (Park et al, 2015) . Mitochondrial morphology also plays a role in terms of NLRP3 sensing and response to viral infection. Upon infection with RNA viruses such as influenza virus, NLRP3 and MAVS associate with MFN2 in a mitochondrial membrane potential (DΨm)-dependent manner. MFN2 associates with the NLRP3 inflammasome through its central 4,3 hydrophobic heptad repeat region 1 (HR1) to recruit adaptor protein ASC and procaspase-1 and form the NLRP3 inflammasome (Ichinohe et al, 2013) . Sensing of single-stranded RNA viruses such as influenza virus has also been shown to trigger activation of the serine-threonine kinases RIP1 and RIP3. This promoted activation of DRP1 and its translocation to mitochondria to drive mitochondrial fission, induction of mtROS, the formation of mitochondrial aggregates in the perinuclear space, and activation of the NLRP3 inflammasome . These results are in contrast to the aforementioned study which indicated mitochondrial elongation is necessary for NLRP3 inflammasome assembly (Park et al, 2015) . As we will see later on, different pathogens modulate mitochondrial dynamics through various mechanisms. Nevertheless, these results demonstrate the importance of mitochondrial dynamics in NLRP3 inflammasome assembly and activation, a crucial function of macrophages during infection. Dendritic cells (DCs) specialise in antigen recognition, uptake and processing, and subsequent antigen presentation to T cells. As such, DCs are the bridge between innate and adaptative immune responses. DCs are classified into different subsets depending on their origin, localisation and function, and they are strategically located throughout the body as the first line of pathogen sensing. In humans, there are two main subsets of DC: myeloid DCs (mDCs) participate in anti-bacterial and anti-fungal immune responses, while plasmacytoid (pDCs) are involved in anti-viral responses (Collin & Bigley, 2018) . Mitochondrial metabolism plays a crucial role in DC differentiation (Zaccagnino et al, 2012) , as metabolism directs the activation state and subtypes of DCs (Pearce & Everts, 2015) . Specifically regarding mitochondrial dynamics, there are very few studies on the role of fission and fusion in DC function. Mitochondrial fusion is induced during GM-CSF-stimulated differentiation of bone marrow progenitor cells to immature dendritic cells, which is accompanied by the upregulation of mitochondrial fusion proteins such as OPA1 and MFN2 (Fig 2) (Ryu et al, 2014) . TLR7 and TLR8 stimulation increased protein expression of DRP1 and induced mitochondrial fragmentation mDCs. Meanwhile, in pDCs, TLR7/8 stimulation increased MFN2 expression and mitochondrial content. These findings reveal that TLR7/8 stimulation differentially regulates mitochondrial dynamics in distinct human DC subsets, which contributes to their activation (Basit et al, 2018) . Interestingly, infection of BMDCs with influenza A virus (IAV) was sensed by Nucleotide-binding oligomerisation domain-containing protein 2 (NOD2) and RIPK2 and promoted mitophagy, which in turn cleared damaged mitochondria to avoid overactivation of NLRP3 inflammasome. Upon interaction with T cells, DCs mobilise their mitochondria to the immune synapse which is the contact site between the DC and T cell. This is accompanied by partial depolarisation of membrane potential, high levels of mtROS, and mitophagy, which could be a homeostatic mechanism to control the quality of mitochondria in this region (G omez-Cabañas et al, 2019). Further investigations are needed to fully elucidate how mitochondrial dynamics affects DC function and the impact this has on the critical role of DCs and their interaction with T cells in bridging the innate and the adaptive immune response. antigen-specific T or B cell, leading to cell priming, activation and differentiation, which usually occurs within the specialised environment of lymphoid tissue. Secondly, the effector response takes place due to activated T cells leaving the lymphoid tissue and homing to the disease site, or due to the release of antibodies from activated B cells into blood and tissue (Parkin & Cohen, 2001) . During infection, na€ ıve T cells (T N ) challenged with an antigen rapidly proliferate into effector T cells (T E ). The majority of T E cells undergo cell death, while a few long-lived memory T cells (T M ) remain after the infection diminishes. T M cells can be reactivated into rapidly expanding T E cells if a similar infection occurs in order to quickly curtail the infection. Regulatory T cells (Tregs) suppress the proliferation and function of effector T cells. T-cell subtypes (T N , T E , T M and Treg) have distinct functions and metabolic profiles which are intrinsically linked to changes in mitochondrial morphology (Weinberg et al, 2015) . Formation of the immune synapse (IS) is essential for T-cell activation. The IS formation induces redistribution of many signalling molecules and it has been shown that the redistribution of mitochondria to the IS is required for T-cell activation and subsequent differentiation (Quintana et al, 2007) . Following an APC-T-cell interaction, DRP1 is recruited to the mitochondria to mediate mitochondrial positioning at the IS. Upon Drp1 knockdown in T cells, mitochondrial translocation towards the IS was reduced. Moreover, Drp1 knockdown decreased membrane potential and ATP production. The phosphorylation of myosin is an ATPdependent process necessary for myosin activation and activated myosin is required for IS formation (Ilani et al, 2009 ). Therefore, Drp1 and its control of mitochondrial morphology and ATP production through control of myosin directly impact IS organisation function. Activated T cells produce mtROS, and this process is also dependent on mitochondrial fission. mtROS are required in the activation of the transcription factor NF-jB, which transcribes IL-2. Inhibition of DRP1 by Mdivi-1 reduced IL-2 mRNA levels and T-cell proliferation (Fig 2) . These results suggest that DRP1 and mitochondrial fission impact mitochondrial position and activity at the IS, T-cell receptor (TCR) proximal signalling and IL-2 production. This illustrates the fundamental role of mitochondrial dynamics for T-cell biology and function (Baixauli et al, 2011) . T E cells augment anabolic pathways of metabolism such as aerobic glycolysis, while T M cells engage catabolic pathways, like fatty acid oxidation (FAO), and these metabolic differences are reflected in mitochondrial morphology. T E cells have decreased expression of the fusion proteins MFN2 and OPA1 and high levels of active DRP1 (Ser616 phosphorylation), leading to punctate mitochondria. On the other hand, T M cells have increased protein expression of MFN2 and OPA1 to maintain fused networks. In terms of T M function, OPA1 appears crucial, as its deletion caused defects in T M survival (Fig 2) . Fusion in T M cells configured ETC complex associations favouring OxPhos and FAO, while fission in T E cells led to cristae expansion, reduced ETC efficiency which promoted aerobic glycolysis. Therefore, mitochondrial dynamics in T cells shapes the metabolic and cellular fate of T cells (Buck et al, 2016; Rambold & Pearce, 2018) . B lymphocytes mature in the bone marrow and move through the lymphatic system to circulate throughout the body. Their main role is to generate antigen-specific antibodies. B-cell activation requires two main signals: firstly, the recognition of the antigen by the B-cell antigen receptor (BCR), followed by a second signal provided by helper T cells (Th), which express the co-stimulatory molecules CD40 and cytokines, such as IL-4 and IL-21. Collectively, this provides the necessary microenvironment for the activation and subsequent proliferation of B cells and antibody production (Crotty, 2015) . Mitochondrial remodelling occurs during B-cell activation. A few studies have shown that mitochondrial mass and volume increased in B cells stimulated with CpG alone or CpG plus anti-IgM in comparison with those B cells stimulated with anti-IgM alone. Activated B cells increase glucose uptake, TCA cycle and OxPhos and have fragmented mitochondria (Fig 2) , while na€ ıve B cells maintain a predominance of elongated mitochondria (Caro-Maldonado et al, 2014; Waters et al, 2018) . These findings are similar to those conducted in T cells; however, it was found that na€ ıve B cells have significantly fewer mitochondria in comparison to na€ ıve T cells (Ron-Harel et al, 2016) . It is typically reported that elongated mitochondria are associated with increased OxPhos, while fragmented mitochondria have reduced OxPhos capacity (Galloway et al, 2012) . Perhaps this morphological strategy is employed by B cells to support rapid, B-cell proliferation and expansion to initiate a humoral immune response (Waters et al, 2018) . These studies suggest how B-cell metabolism adapts with stimulation and reveals unexpected details of mitochondrial dynamics at the start of a humoral immune response. Although there is evidence of how mitochondrial dynamics are involved in the activation and differentiation of lymphocytes, future studies are needed to fully delineate why and how mitochondrial dynamics change in T and B cells as they go through stages of differentiation and activation and also the consequences of this on their cellular function. Mitochondria play essential roles in anti-viral and anti-bacterial signalling in cells, including the RLR and TLR signalling pathways to sense the presence of pathogens. Therefore, it is of no surprise that many pathogens have evolved strategies to manipulate fission and fusion to aid in their own survival (Tiku et al, 2020) . Viruses and bacteria infect both "traditional" immune cells and "non-traditional" host immune cells such as epithelial and endothelial cells to circumvent clearance by immune cells. Viruses are obligate intracellular pathogens which hijack host cell machinery in order to survive and replicate. Viruses are reliant on host cells' metabolism for energy requirements, and their modulation of molecular machinery and mitochondrial dynamics leads to alterations in organelle function. Mitochondria participate in host anti-viral immunity through MAVS activation and mitochondrial dynamics. Viral pathogen-associated molecular patterns (PAMPs) are recognised by intracellular pattern recognition receptors (PRRs) such as RIG-I, MDA-5 and LGP2, which sense viral RNA in the cytoplasm and activate MAVS through binding via CARD domains. MAVS is located in the OMM and once activated it associates with adaptor proteins such as TRAF2, TRAF6 and TRADD which recruits TRAF3 and TANK. This recruitment triggers the activation of TBK1 and IKK epsilon which promotes the phosphorylation and subsequent dimerisation of the transcription factors IRF3 and IRF7, necessary for the mRNA expression of type I IFNs. Concurrently, the MAVS/TRADD complex recruits RIP1 and FADD, leading to IKK activation. IKK phosphorylates the NF-kB inhibitor IkBa, releasing NF-kB which then drives pro-inflammatory cytokine mRNA expression. MAVS is also known to interact with Stimulator of interferon genes (STING) and TOM70 in the mitochondria, both of which are required for IRF3 production of type I IFNs upon viral sensing by RIG-I (Loo & Gale, 2011) (Fig 3) . Studies have shown that mitochondrial dynamics play an important role in the viral immune response, with elongation and fragmentation of mitochondria affecting RIG-I-like receptor (RLR) signalling. In epithelial cells, RLR signalling leads to mitochondrial elongation through interaction of MAVS with the mitochondrial fusion protein MFN1. Upon viral signalling, the higher isoform of MAVS becomes degraded, leading to the release of MFN1 which promotes mitochondrial fusion. Fusion allows for increased interaction between MAVS and STING, which enhances type I IFN expression. Cells with a mutated version of Drp1 had elongated mitochondria and were also found to have enhanced activation of the IFN-b promoter (Castanier et al, 2010) . Similarly, another study found that MFN1 positively regulates anti-viral responses, necessary for MAVS activation and subsequent viral signalling in mouse embryonic fibroblasts (MEFs) (Onoguchi et al, 2010) . Conversely, loss of MFN2 was found to enhance anti-viral signalling mediated by MAVS. Moreover, the same group found that MEFs lacking MFN1 and MFN2 had defective anti-viral immune responses and a loss of mitochondrial membrane potential, with decreased MAVS signalling and subsequently impaired expression of IFN-b and IL-6 (Yasukawa et al, 2009) . These studies highlight the importance of mitochondrial dynamics in the viral immune response, by fine-tuning RLR signalling via MAVS and subsequently impacting interferon synthesis and viral clearance. Clearly, mitochondrial dynamics is important in executing viral signalling pathways and inflammatory responses during infection. However, viruses have been able to take hijack some of these mechanisms in order to propagate their own survival. As we will see in the subsequent section, this involves increased mitochondrial fusion or fission depending on the virus and host cell type they infect. Below we outline several examples of viruses which specifically manipulate mitochondrial remodelling in host cells in order to enhance their own replication. Severe acute respiratory syndrome (SARS) is a viral respiratory disease caused by (+)ssRNA SARS-associated coronaviruses, including SARS-CoV-1 and more recently SARS-CoV-2. These coronaviruses infect epithelial cells in the lungs by binding the ACE2 receptor. SARS-CoV-1 disturbs type I IFN pathways in order to circumvent clearance. The genome of SARS-CoV-1 encodes an accessory protein ORF-9b, which has been shown to have a functional role in altering host cell mitochondrial dynamics and manipulating interferon signalling pathway components, disrupting the inflammatory response to the virus. Expression of ORF-9b in HEK293T cells and THP-1 cells led to a reduction in DRP1 levels and increased mitochondrial elongation driven by MFN2 (Fig 4A) (Shi et al, 2014) . As mentioned previously, MFN2 inhibits MAVS which increases IFN production (Yasukawa et al, 2009 ), indicating that SARS-CoV-1 employs ORF-9b to induce fusion and decrease the RIG-like receptors (RLR) detect viral RNA and activate downstream signalling pathways to initiate the immune response. RIG-1 and MDA-5 recognise and bind to viral mRNA which leads to activation of MAVS on the mitochondrial membrane. MAVS dimerises and associates with adaptor proteins such as TRAF2/6 and TRADD. This leads to the recruitment of TRAF3 and TANK, which activates TBK1 and IKK epsilon. IRF3 and IRF7 are phosphorylated by TBK1 and IKK epsilon, leading to homodimerisation and translocation of IRF3 and IRF7 to the nucleus where they promote the expression of type I IFNs. The association of TRADD with MAVS leads to the recruitment of FADD and RIP1 which activates IKK. IKK phosphorylates IkB which becomes ubiquinated and targeted for degradation, allowing NF-kB to translocate to the nucleus where it promotes the expression of pro-inflammatory genes. Viral sensing via RIG-1 can also lead to the association of MAVS with STING, located at the ER, which has been shown to be important for IRF3 type I IFN production. ª 2021 The Authors EMBO reports 22: e53086 | 2021 IFN response. Moreover, ORF-9b was found to bind to MAVS, leading to MAVS degradation, disrupting anti-viral signalling and subsequently IFN production (Shi et al, 2014) . Thus, SARS-CoV-1 modulates mitochondrial dynamics in host cells in order to reduce the type I IFN response and propagate its survival. SARS-CoV-2 has also been implicated in manipulating mitochondrial dynamics in host cells. SARS-CoV-2 also expresses ORF-9b, which was reported to interact with TOM70, a subunit which recruits MAVS pathway components to the OMM (Gordon et al, 2020) . This may have the same effect on host cell mitochondrial dynamics as ORF-9b expression in SARS-CoV-1. Moreover, SARS-CoV-2 also expresses ORF-9c which reportedly interacts with components of the ETC, suggesting a possible role of ORF-9c in manipulating host cell OxPhos (Gordon et al, 2020) . Dengue virus (DENV) is a mosquito-borne (+)ssRNA flavivirus and the causative agent of dengue fever. DENV targets myeloid-derived cells such as monocytes, macrophages and dendritic cells, as well as endothelial cells and hepatocytes. DENV possesses the protease NS2B3 which can cleave STING, an adaptor protein required for IFN signalling. By cleaving STING, DENV circumvents the innate immune response. One study found that on top of targeting STING, DENV protease NS2B3 also targets MFN1 and MFN2 for degradation, which was found to impair mitochondrial fusion and IFN signalling in epithelial cell lines (Fig 4A) . Conversely, infection of hepatoma cells with DENV led to mitochondrial elongation by reducing DRP1Ser616 phosphorylation. By inducing fusion, DENV infection led to the formation of convoluted membranes from the ER, leading to disrupted contact between the ER and mitochondria which ultimately reduced MAVS signalling, inhibiting the anti-viral response (Chatel-Chaix et al, 2016) . Similarly, DENV infection of hepatoma cells and monocyte-derived DCs induced mitochondrial elongation via DRP1 inhibition, with increased mitochondrial respiration and ATP production. Conversely, when mitochondrial fragmentation was reversibly induced with CCCP in epithelial cells, viral replication was inhibited. Removal of CCCP resulted in increased elongation and viral titres to levels in untreated DENV-infected epithelial cells (Barbier et al, 2017) . DENV manipulates mitochondrial dynamics of host cells in order to promote its survival; however, the mechanism employed and outcome appears to be cell type-dependent. Therefore, more extensive investigations employing all the different cell types which DENV infects is needed to fully appreciate how DENV influences mitochondrial remodelling. swine flu pandemic, as well influenza epidemics which occur each year. IAV employs numerous mechanisms to promote its survival in epithelial cells, including manipulation of mitochondrial dynamics. In infected cells, the viral protein PB1-F2 binds to MAVS to inhibit RLR signalling and thus reduce anti-viral immunity (Varga et al, 2012) . Furthermore, PB1-F2 translocates to the mitochondria leading to increased mitochondrial fission and loss of membrane potential (Fig 4B) (Zamarin et al, 2005; Yoshizumi et al, 2014) . Knockdown of Drp1 inhibited mitochondrial fission induced by PB1-F2. The Drp1-dependent changes in host cell mitochondrial morphology correlated with impaired RIG-I signalling and inhibition of the NLRP3 inflammasome (Yoshizumi et al, 2014) . In contrast to the above findings, a recent study found that infection of epithelial cells with IAV unexpectedly induced mitochondrial elongation. Elongation was observed with infection using H1N1, H3N2 and influenza B strain. Transfection of cells with influenza RNA was sufficient to induce mitochondrial elongation, decrease DRP1 presence at the mitochondria and propagate the IFN response. Treatment of IAV-infected epithelial cells with the fissioninducing molecule Mito-C reduced viral replication and reversed IAV-induced elongation in infected cells (Pila-Castellanos et al, 2021) . The differences between the effects of IAV infection in epithelial cells between the above studies may be due to experimental conditions and varying degrees of cellular stress which can impact mitochondrial morphology. Therefore, it appears that IAV targets mitochondrial-dependent mechanisms and morphology to subvert host cell anti-viral responses and propagate its survival in host cells. Modulation of mitochondrial dynamics has been observed both for hepatitis B (HBV) and hepatitis C (HCV) viruses. Both HBV and HCV infect hepatocytes, leading to chronic liver damage and eventually hepatocellular carcinoma (HCC). Importantly, infection of host cells with HBV and HCV leads to dysregulation of mtROS generation, Ca 2+ signalling and mitochondrial dysfunction. Infection of hepatocytes with HBV or HCV induced mitochondrial fragmentation via phosphorylation of DRP1 (Ser616), leading to DRP1 translocation to the mitochondria and mitophagy, which in turn inhibited mitochondrial induced apoptosis (Fig 4B) . Moreover, the HCV protein NS5A has been reported to colocalise with and cleave MAVS in the mitochondria of infected hepatocytes, leading to disruption of IFN signalling in cells (Refolo et al, 2019) , while other core HCV proteins can induce phosphorylation of DRP1 (Ser616) (Kim et al, 2014) . Inhibiting DRP1 activity, thus promoting fusion, led to increased apoptosis and increased IFN synthesis in HCV-infected cells, suggesting that mitochondrial fission promoted viral persistence in cells. These viruses can manipulate its host cell through the mitochondria to prevent cellular apoptosis. This intelligent strategy of preventing cell death in infected cells leads to viral persistence of HBV and HCV (Kim et al, , 2014 . Overall these studies demonstrate that both HBV and HCV employ similar mechanisms to modulate host cell mitochondrial dynamics in order to subvert anti-viral responses. Therefore, viruses manipulate host cell mitochondrial dynamics to impact host cell mitophagy, apoptosis, as well as anti-viral signalling. These physiological changes caused by disrupted mitochondrial dynamics severely impact the immune systems' ability to clear the virus, leading to persistent infection. Further studies are necessary to fully tease apart exactly how certain viruses manipulate host cell mitochondrial dynamics to circumvent the immune response. A greater understanding in this area may lead to the development of much needed new anti-viral drugs. Given the importance of mitochondria in the anti-bacterial response, it is of no surprise that several bacteria have evolved mechanisms of circumventing clearance by manipulating host cell mitochondrial dynamics to maintain a favourable environment for pathogen survival. Most bacteria which target mitochondrial remodelling tend to be intracellular (although there are some exceptions) and most of the strategies employed by bacteria lead to mitochondrial fission as we will outline in this section. There have been numerous studies to date outlining the role of mitochondria in innate immune signalling, and macrophages are the main players in the anti-bacterial response. TLR signalling is a pivotal component of the innate immune response, sensing PAMPs and DAMPs during infection ultimately leading to the production of pro-inflammatory mediators required to clear pathogens from the body. Mitochondria play a role in augmenting the inflammatory response upon TLR stimulation . For example, upon TLR4 stimulation by LPS, macrophages undergo a metabolic switch from OxPhos to glycolysis. This metabolic change to glycolysis is accompanied with an increase in fragmented mitochondria and increased mtROS production, which is crucial for bacterial clearance. This increase in mtROS production occurs through TLR recruitment of mitochondria to phagosomes, where TRAF6 translocates to the mitochondria. Macrophages lacking TRAF6 have reduced bactericidal activity, demonstrating the importance of translocation of TRAF6 to the mitochondria upon TLR stimulation. Mitochondria also participate in TLR1-and TLR2-mediated signalling (gram-negative bacteria and mycoplasma sensing) in a similar manner to TLR4 . Below we outline how several bacteria manipulate host cell mitochondrial dynamics in order to create an appropriate intracellular niche for bacterial survival and replication. Most early work investigating bacterial manipulation of mitochondrial dynamics in host cells was carried out using Listeria monocytogenes. L. monocytogenes is a gram-positive, facultative anaerobic intracellular bacterium well known for causing the disease listeriosis. L. monocytogenes invades epithelial cells, while macrophages also internalise L. monocytogenes via phagocytosis. Once internalised, the bacterium must escape the phagosome in order to survive in the cytosol. It does so by producing a pore-forming toxin known as listeriolysin O (LLO). Upon lysis of the phagosome, L. monocytogenes escapes into the cytosol where it hijacks the host cell's actin filaments via the bacterial protein ActA. This allows the bacterium the ability to move within the cell and subsequently spread to other cells. L. monocytogenes can dramatically alter the mitochondrial dynamics of its host cell, L. monocytogenes infection induces mitochondrial fragmentation in the host cell mitochondria (Fig 4B) (Stavru et al, 2011) . Mitochondrial fragmentation was found to be ª 2021 The Authors EMBO reports 22: e53086 | 2021 dependent on Ca2+ influx into the mitochondria which led to a decrease in mitochondrial respiration, membrane potential and intracellular ATP levels. These changes were caused by the poreforming actions of LLO and were necessary for efficient L. monocytogenes infection. Interestingly, fragmentation of the host cell mitochondria only occurred in early stages of infection, with no observed alterations of mitochondrial architecture at late stages of infection. Inducing mitochondrial fragmentation in cells prior to infection strongly impaired L. monocytogenes infection, while more infection was observed in host cells with hyperfused mitochondria. The conclusion from this study was that mitochondria which are more fused allows for L. monocytogenes invasion, and upon entry into the cell L. monocytogenes induces fission to impair the host cell's ability to clear the pathogen by reducing intracellular ATP levels (Stavru et al, 2011) . Legionella pneumophilia is a gram-negative aerobic bacterium and the causative agent of a severe form of acute pneumonia known as Legionnaires' disease. First described over 40 years ago, this intracellular bacterium infects alveolar macrophages and epithelial cells and replicates in vacuoles following internalisation. During infection of human monocyte-derived macrophages (hMDMs), L. pneumophilia uses a type IV secretion system (T4SS) in order to manipulate host cell mitochondrial dynamics to promote an environment suitable for its replication. This process involves the T4SS effector MitF which induced DRP1-dependent mitochondrial fragmentation ( Fig 4B) and leads to a Warburg-like phenotype in the host cell, with decreased mitochondrial respiration and increased glycolysis. MitF is also a known activator of host cell Ran GTPase and has been shown to manipulate the host cell's cytoskeleton and cell migration upon infection, and it is thought to execute mitochondrial fragmentation through interaction with this GTPase. Silencing DRP1 was found to reduce bacteria-induced fragmentation, as well as reducing replication of L. pneumophilia (Escoll et al, 2017) . Therefore, like L. Monocytogenes, L. pneumophilia induces fragmentation in host cell mitochondria to promote its survival in the cell. Mycobacterium tuberculosis is a facultative intracellular bacterium which infects monocytes and alveolar macrophages in the lungs and the causative agent of tuberculosis. Once phagocytosed, the bacterium prevents the acidification and fusion of the phagosome with the lysosome, allowing its survival and replication until it initiates necrosis in order to spread to other cells. Aguilar-Lopez et al found that two M. tuberculosis virulence factors, LprG and PE_PGRS33, had opposing effects on hMDM mitochondrial morphology. LprG is known to be immunosuppressive as administration with M. tuberculosis in mice leads to exacerbated infection and decreased survival, while PE_PGRS33 plays a role in the entry of M. tuberculosis into macrophages via TLR2. Stimulation of hMDMs with LprG led to mitochondrial fragmentation (Fig 4B) , reduced oxygen consumption and a lower respiratory capacity compared to control cells and affected mitochondrial calcium uptake. Conversely, PE_PGRS33 induced mitochondrial fusion with no differences in respiratory capacity or calcium uptake. The authors suggest that the bacterial virulence factors may act on mitochondria at different stages of infection. Macrophage infection with M. tuberculosis leads to Warburg metabolism, with increased glucose uptake and glycolytic enzyme activity, which is necessary for pathogen clearance (Aguilar-L opez et al, 2019). Perhaps mitochondrial fragmentation is first induced by intracellular bacterium in order to provide a suitable environment for effective infection and survival by impairing host cell metabolism, while in later stages fragmentation is reduced in order not to damage the infected host cell enabling persistent infection. Many other bacteria appear to manipulate mitochondrial dynamics to promote their survival. Chlamydiae trachomatis is an obligate intracellular pathogen which infects epithelial cells and causes trachoma. Mitochondria are a key target of C. trachomatis due to the role of mitochondria in cell bioenergetics and apoptosis. Cells infected with C. trachomatis display aberrant metabolism, with increased NADPH consumption and lipid biosynthesis. Upon infection of epithelial cells, C. trachomatis elevated intracellular cAMP levels which was followed by phosphorylation of DRP1 (Ser637) leading to mitochondrial elongation (Fig 4A) , increased ATP production. These mitochondrial changes led to increased C. trachomatis growth (Liang et al, 2018; Kurihara et al, 2019) . Mitochondrial elongation occurred during early infection, with late stage infection characterised by fragmented mitochondria (Kurihara et al, 2019; Rother et al, 2019) . Other studies have found mitochondrial elongation occurs during later stages of infection (Chowdhury et al, 2017) which may be due to differences in host cells employed as well as differences in culture medium and techniques. Shigella flexneri is a gram-negative intracellular bacteria and the causative agent of bacillary dysentery known as shigellosis. S. flexneri infects myeloid immune cells as well as intestinal epithelial cells. In HeLa cells, S. flexneri induces mitochondrial fragmentation through DRP1 (Fig 4B) . Silencing of Drp1 was found to reduce the ability of S. flexneri to spread from cell-to-cell and reduce the size of S. flexneri plaques (Lum & Morona, 2014) . Therefore, in summarising the literature, it is becoming clear that altering mitochondrial morphology underpins the capacity of a cell to mount an anti-viral or anti-bacterial response. As such many pathogens have developed their own mechanisms of manipulating host cell mitochondria and morphology as a counter measure to subvert clearance and allow their survival. Simultaneously, the host cell is continually alter its morphology for anti-pathogen signalling at the different stages of infection. The winner of this battle determines the outcome of infection, whether a successful immune response is executed or whether the pathogen successfully circumvents clearance. However, it should be noted that the majority of studies discussed use in vitro model systems. Far less is known about pathogen infection on host cell mitochondrial dynamics in an in vivo setting and this requires significant investigation. Therefore, this area of research holds promise to offer a new range of therapeutics centred around remodelling host cell mitochondria to enhance pathogen clearance. Controlling mitochondrial dynamics as a therapeutic approach Given that mitochondrial dynamic homeostasis is essential for normal cellular functions, mitochondrial remodelling has the 12 of 18 EMBO reports 22: e53086 | 2021 ª 2021 The Authors potential to be a valuable therapeutic target in treating recurrent and persistent bacterial and viral infections (Table 1) . Recently, it has been shown that the pro-fission compound Mito-C has anti-viral effects on cells through altering mitochondrial morphology to increase mitochondrial-ER contact sites (Molino et al, 2020) . Mito-C was found to promote recruitment of DRP1 to mitochondria-ER sites to induce mitochondrial fragmentation which inhibited dengue virus replication in host cells. Another study found that IAV infection induced mitochondrial elongation in epithelial cells which reduced mitochondrial-ER contact sites and also anti-viral signalling. Again, treatment of IAV-infected cells with Mito-C induced mitochondrial fragmentation and inhibited IAV replication. The increased mitochondria-ER contact sites induced by Mito-C treatment correlated with enhanced IFN activation through the RIG-I signalling pathway (Pila-Castellanos et al, 2021) . Thus, Mito-C may have broad anti-viral properties against viruses which induce mitochondrial elongation and are sensed via RIG-I. For example, SARS-CoV-1 and SARS-CoV-2 both express ORF-9b which induces mitochondrial elongation upon epithelial cell infection. Mito-C may therefore prove effective in inhibiting SARS-CoV-1/2 replication via modulating mitochondrial dynamics in host cells. Mdivi-1 is a well-documented inhibitor of DRP1 and modulator of mitochondrial dynamics in cells. In numerous infection models, inhibition of DRP1 activity with Mdivi-1 may be a viable therapeutic option. In a model of cell sepsis-induced acute kidney injury (S-AKI), Mdivi-1 treatment inhibited mitochondrial fragmentation which prevented the release of mitochondrial contents and decreased NLRP3 activation in renal tubular epithelial cells. Mdivi-1 treatment also alleviated kidney damage in LPS-induced S-AKI mice . The NLRP3 inflammasome is now a target of significant interest in the treatment of inflammatory diseases (Coll et al, 2015) , and NLRP3 inflammasome activation serves as a critical step in the inflammatory response against pathogens. Targeting NLRP3 inflammasome activity in different cell types through modulation of mitochondrial dynamics may therefore represent another therapeutic option. Mdivi-1 may also be useful in the treatment of allergies and atopic dermatitis, as inhibition of mitochondrial fission in mast cells prevented degranulation and TNF secretion from cells (Zhang et al, 2011) . It should be noted, however, that in certain cell types, Mdivi-1 inhibited mitochondrial complex I, impairing mitochondrial respiration with no mitochondrial elongation or reduction in DRP1 GTPase activity reported (Bordt et al, 2017) . Therefore, the effects of Mdivi-1 treatment may depend on cell type, which should be considered when focusing on mitochondrial dynamic-based therapies. Inhibition of DRP1 and mitochondrial fission in cardiomyocytes with P110 has been shown to be protective against in vitro and in vivo models of septic cardiomyopathy (Haileselassie et al, 2019) . Therefore, pharmacological modulation of mitochondrial dynamics is a viable therapeutic option. The protective effects of fission or fusion depend on the type of infection, target cell type or inflammatory condition. Melatonin is known to prevent mitochondrial damage by promoting mitochondrial fusion, which limits mitochondrial fission induced oxidative stress and enhancing mitochondrial quality. Melatonin limits oxidative stress by enhancing anti-oxidative enzymes as well as scavenging harmful mtROS and stimulates ATP synthesis in cells. A recent study suggested melatonin may be a potential adjuvant for treatment of COVID-19 by enhancing mitochondrial quality and dampen hyper-inflammatory responses to infection by the virus . MitoQ is an orally active antioxidant which targets mitochondrial dysfunction in an in vitro model of Parkinson's disease induced by 6-hydroxydopamine (6-OHDA) administration. Pretreatment of neuronal cells with MitoQ inhibited mitochondrial translocation of DRP1 and abrogated 6-OHDA-induced mitochondrial fission (Solesio et al, 2013) . This study provides a compelling insight into MitoQ as a therapy for diseases involving mitochondrial fragmentation and oxidative stress. It would be interesting to investigate the potential of MitoQ in limiting the spread of pathogens which induce a fragmented phenotype in host cells for survival. BGP-15 is a hydroxylamine derivative and has been shown to have extensivecytoprotective effects including reducing oxidative stress and increasing mitochondrial biogenesis. Recently, it has been demonstrated that BGP-15 promotes mitochondrial fusion by activating optic atrophy 1 (OPA1), preventing mtROS induced fragmentation in multiple cell lines and in an in vivo model of pulmonary arterial hypertension (PAH). Mitochondrial fragmentation is an important factor in the development and progression of multiple diseases including PAH. Treatment of BGP-15 in a mouse model of PAH induced mitochondrial fusion with a consequent reduction of inflammatory cell infiltration into the lungs (Szabo et al, 2018) . This study provides therapeutic evidence of BGP-15, which may also exert protective effects through modulation of mitochondrial morphology against viral and bacterial infections in host cells. Finally, it has been shown that pharmacologically targeting MFN1 and MFN2 using 6-phenylhexanamide derivative mitofusin activators induces fusion in neurons. Use of these activators was shown to reverse mitochondrial dysfunction in nerve neurons in a murine model of Charcot-Marie-Tooth disease type 2A (CMT2A), a genetic mutation which impairs MFN2 function and thus mitochondrial fusion (Dang et al, 2020) . The promising effects of this compound in treating genetic diseases such as CMT2A suggests that activating MFN1/MFN2 may be a viable therapeutic option for reducing infection in instances where a pathogen induces mitochondrial fragmentation for survival. It has become increasingly clear that mitochondria perform in numerous ways in addition to their classical label as "the powerhouse of the cell". The last two decades of research has clearly shown the importance of mitochondrial dynamics in immune cell function and how this organelle is central to anti-bacterial and antiviral signalling pathways. Due to the importance and efficiency of mitochondria in pathogen clearance, numerous bacteria and viruses have evolved mechanisms to hijack mitochondrial dynamics for their own survival. In doing so, these microorganisms are manipulating mitochondrial dynamic machinery in an attempt to create a suitable environment in which to replicate and to hide intracellularly from patrolling immune cells. Understanding the biology underlying this battle between microorganisms and this organelle, which may itself be a descendent of bacteria, may provide a new class of anti-bacterial, anti-viral and immunomodulatory targets (see Box 1). . LprG and PE_PGRS33 Mycobacterium tuberculosis virulence factors induce differential mitochondrial dynamics in macrophages Neutrophil extracellular trap formation requires OPA1-dependent glycolytic ATP production Diverse roles of mitochondria in immune responses: Novel insights into immunometabolism Mitochondrial dynamics -mitochondrial fission and fusion in human diseases Mechanisms of immune resolution The mitochondrial fission factor dynamin-related protein 1 modulates T-cell receptor signalling at the immune synapse Dengue virus induces mitochondrial elongation through impairment of Drp1-triggered mitochondrial fission Human dendritic cell subsets undergo distinct metabolic reprogramming for immune response Circadian clock regulates the host response to Salmonella The dynamin-related GTPase Dnm1 regulates mitochondrial fission in yeast The Putative Drp1 Inhibitor Is a Reversible Mitochondrial Complex I Inhibitor that Modulates Reactive Oxygen Species A mitofusindependent docking ring complex triggers mitochondrial fusion in vitro Mitochondrial Box 1. In need of answers • Why do distinct pathogens differentially manipulate mitochondrial dynamics in varied host cells? • Can mitochondrial dynamics in host cells be therapeutically targeted to make host cells less viable for pathogenic infection? • Can the mitochondrial dynamic machinery in immune cells be targeted to enhance innate and adaptive responses to limit infection? • Can we elucidate the missing mechanisms of mitochondrial fission and fusion through studying pathogen manipulation of mitochondrial dynamics? dynamics controls T Cell fate through metabolic programming Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells Mitochondrial dynamics regulate the RIG-I-like receptor antiviral pathway Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria Dengue virus perturbs mitochondrial morphodynamics to dampen innate immune responses Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development Constriction of the mitochondrial inner compartment is a priming event for mitochondrial division Chlamydia preserves the mitochondrial network necessary for replication via microRNA-dependent inhibition of fission A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases Human dendritic cell subsets: an update Post-transcriptional circadian regulation in macrophages organizes temporally distinct immunometabolic states Reversible phosphorylation of Drp1 by cyclic AMPdependent protein kinase and calcineurin regulates mitochondrial fission and cell death A brief history of T cell help to B cells Il-15 re-programming compensates for NK cell mitochondrial dysfunction in HIV-1 infection Discovery of 6-phenylhexanamide derivatives as potent stereoselective mitofusin activators for the treatment of mitochondrial diseases VDAC1 selectively transfers apoptotic Ca 2 signals to mitochondria Eight human OPA1 isoforms, long and short: What are they for? The immune system. First of two parts Mitochondrial arginase-2 is essential for IL-10 metabolic reprogramming of inflammatory macrophages MiR-125b controls monocyte adaptation to inflammation through mitochondrial metabolism and dynamics Regulation of OPA1 processing and mitochondrial fusion by m-AAA protease isoenzymes and OMA1 Legionella pneumophila modulates mitochondrial dynamics to trigger metabolic repurposing of infected macrophages ER tubules mark sites of mitochondrial division Mitochondrial morphology-emerging role in bioenergetics Mitochondrial dynamics controls anti-Tumour innate immunity by regulating CHIP-IRF1 axis stability Immunological synapse formation induces mitochondrial clustering and mitophagy in dendritic cells A SARS-CoV-2 protein interaction map reveals targets for drug repurposing Drp1/Fis1 interaction mediates mitochondrial dysfunction in septic cardiomyopathy Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus Mitochondrial protein mitofusin 2 is required for NLRP3 inflammasome activation after RNA virus infection T cell antigen receptor signaling and immunological synapse stability require myosin IIA Calcium signalling and related ion channels in neutrophil recruitment and function Mitofusin 1 and 2 play distinct roles in mitochondrial fusion reactions via GTPase activity Cell-free mitochondrial fusion assay detected by specific protease reaction revealed Ca2+ as regulator of mitofusin-dependent mitochondrial fusion PINK1 phosphorylates ubiquitin to activate parkin E3 ubiquitin ligase activity Accelerated publication: Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at Ser65 Hepatitis B virus disrupts mitochondrial dynamics: induces fission and mitophagy to attenuate Hepatitis C virus triggers mitochondrial fission and attenuates apoptosis to promote viral persistence The mitochondrial calcium uniporter is a highly selective ion channel An actin-dependent step in mitochondrial fission mediated by the ER-associated formin INF2 Ubiquitin is phosphorylated by PINK1 to activate parkin Mitochondria and mitophagy: The yin and yang of cell death control Chlamydia trachomatis targets mitochondrial dynamics to promote intracellular survival and proliferation Van der Bliek AM (1999) C. elegans dynamin-related protein DRP-1 controls severing of the mitochondrial outer membrane The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy Mitochondria in tissue culture Imaging of macrophage mitochondria dynamics in vivo reveals cellular activation phenotype for diagnosis Dynamic energy dependency of Chlamydia trachomatis on host cell metabolism during intracellular growth: Role of sodium-based energetics in chlamydial ATP generation The role of mitochondria in NLRP3 inflammasome activation An inhibitor of DRP1 (Mdivi-1) alleviates LPS-induced septic AKI by inhibiting NLRP3 inflammasome activation Immune signaling by RIG-I-like receptors Dynamin-related protein Drp1 and mitochondria are important for Shigella flexneri infection Granulocyte colony-stimulating factor inhibits the mitochondria-dependent activation of caspase-3 in neutrophils A mitochondria-anchored isoform of the actin-nucleating spire protein regulates mitochondrial division The multifaceted functions of neutrophils Mitochondria: more than just a powerhouse Conformational changes in Dnm1 support a contractile mechanism for mitochondrial fission Identification of novel human monocyte subsets and evidence for phenotypic groups defined by interindividual variations of expression of adhesion molecules Metchnikoff E (1883) Untersuchungen ueber die mesodermalen Phagocyten einiger Wirbeltiere Metabolic regulation of mitochondrial dynamics Hama€ ı A et al (2020) Chemical targeting of NEET proteins reveals their function in mitochondrial morphodynamics ) mTOR controls mitochondrial dynamics and cell survival via MTFP1 Exploring the full spectrum of macrophage activation A guide to immunometabolism for immunologists Crosstalk between circadian rhythmicity, mitochondrial dynamics and macrophage bactericidal activity Virusinfection or 5 0 ppp-RNA activates antiviral signal through redistribution of IPS-1 mediated by MFN1 Macrophage polarization: different gene signatures in M1(Lps+) vs. classically and M2(LPS-) vs. alternatively activated macrophages Cooperative and independent roles of the Drp1 adaptors Mff, MiD49 and MiD51 in mitochondrial fission Mitochondrial cAMP-PKA signaling: what do we really know? Mechanisms of mitophagy in cellular homeostasis, physiology and pathology Mitochondrial dynamics modulate the expression of proinflammatory mediators in microglial cells Defective mitochondrial fission augments NLRP3 inflammasome activation An overview of the immune system Dendritic cell metabolism Mitochondrial morphodynamics alteration induced by influenza virus infection as a new antiviral strategy The role of mitochondrial ROS in antibacterial immunity T cell activation requires mitochondrial translocation to the immunological synapse Mitochondrial dynamics at the interface of immune cell metabolism and function Negative regulation of mitochondrial antiviral signaling protein-mediated antiviral signaling by the mitochondrial protein LRPPRC during hepatitis C virus infection Mitochondria as sensors and regulators of calcium signalling Tracker dyes to probe mitochondrial autophagy (mitophagy) in rat hepatocytes Mitochondrial biogenesis and proteome remodeling promote one-carbon metabolism for T cell activation Modulation of host cell metabolism by chlamydia trachomatis The mitochondrial fusion-related proteins Mfn2 and OPA1 are transcriptionally induced during differentiation of bone marrow progenitors to immature dendritic cells Circadian control of lung inflammation in influenza infection Mgm1p, a dynaminrelated GTPase, is essential for fusion of the mitochondrial outer membrane SARS-coronavirus open reading frame-9b suppresses innate immunity by targeting mitochondria and the MAVS/TRAF3/TRAF6 The mitochondria-targeted anti-oxidant MitoQ reduces aspects of mitochondrial fission in the 6-OHDA cell model of Parkinson's disease OPA1 processing controls mitochondrial fusion and is regulated by mRNA splicing, membrane potential, and Yme1L Listeria monocytogenes transiently alters mitochondrial dynamics during infection Activation of mitochondrial fusion provides a new treatment for mitochondria-related diseases Mitochondrial dynamics: overview of molecular mechanisms Innate rhythms: clocks at the center of monocyte and macrophage function Mitochondrial functions in infection and immunity The mitochondrial protein MTP18 contributes to mitochondrial fission in mammalian cells Fission and selective fusion govern mitochondrial segregation and elimination by autophagy Influenza virus protein PB1-F2 inhibits the induction of type I interferon by binding to MAVS and decreasing mitochondrial membrane potential Identification of new OPA1 cleavage site reveals that short isoforms regulate mitochondrial fusion RNA viruses promote activation of the NLRP3 inflammasome through a RIP1-RIP3-DRP1 signaling pathway Mitochondrial ROS promote macrophage pyroptosis by inducing GSDMD oxidation Mitochondrial fission promotes the continued clearance of apoptotic cells by macrophages Initial B cell activation induces metabolic reprogramming and mitochondrial remodeling Mitochondria in the regulation of innate and adaptive immunity TLR signalling augments macrophage bactericidal activity through mitochondrial ROS Macrophage biology in development, homeostasis and disease Mitofusin 2 inhibits mitochondrial antiviral signaling Influenza a virus protein PB1-F2 translocates into mitochondria via Tom40 channels and impairs innate immunity Dengue virus impairs mitochondrial fusion by cleaving mitofusins Mitochondrial fission mediates high glucose-induced cell death through elevated production of reactive oxygen species An active mitochondrial biogenesis occurs during dendritic cell differentiation Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1 Mitochondrial dynamics in basal and stressful conditions mast cell degranulation and preformed TNF secretion require mitochondrial translocation to exocytosis sites: relevance to atopic dermatitis COVID-19: Melatonin as a potential adjuvant treatment Phosphorylation of dynamin-related protein 1 at Ser616 regulates mitochondrial fission and is involved in mitochondrial calcium uniporter-mediated neutrophil polarization and chemotaxis Mitofusin 2 regulates neutrophil adhesive migration and the actin cytoskeleton License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited The authors declare that they have no conflict of interest.